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Intr
Despite extensive research and an improved standard of
care, sepsis remains a disorder with a high mortality rate.
Sepsis is accompanied by severe metabolic alterations.
However, there are controversies about changes in lipid
profiles in sepsis patients.
Objectives
To examine whether disorders of lipid metabolism are
associated with worse disease activity and mortality.
Methods
We evaluated 117 sepsis and septic shock patients
(65 survivors and 52 non-survivors) who were admitted
to the intensive care unit of a university-affiliated hospi-
tal in Korea. Serum levels of cholesterol, triglyceride
(TG), high-density lipoprotein (HDL), low-density lipo-
protein (LDL), free fatty acid (FFA), and apolipoprotein
(apo) A-I were measured on days 0, 1, 3, and 7. Patients
who had previously used statins or steroids, for treating
lipid diseases or liver diseases were excluded.
Results
Non-survivors showed significantly higher SOFA scores
than survivors (p = 0.008). Non-survivors had low levels of
cholesterol, TG, HDL, LDL, and apo A-I levels on days 0,
1, 3, and 7. In linear mixed model analysis, over time the
variation in TG, LDL, FFA and apo A-I between groups
differed significantly (p = 0.043, p = 0.020, p = 0.005, and
p = 0.015, respectively). However, there were no significant
differences in cholesterol or HDL between groups. Through
multivariate analysis, TG level and SOFA scores were asso-
ciated with mortality on day 0 and day 1 (p = 0.018 and
p = 0.008, respectively). In survival analysis, the high TG
level group showed better prognosis than the other groups
(p = 0.022).
Conclusions
Recently, in two large, multicenter, double-blind, rando-
mized, placebo-controlled studies, simvastatin and rosu-
vastatin did not improve clinical outcomes in acute
respiratory distress syndrome (ARDS) or sepsis-associated
ARDS patients. Similary, in contrast to previous studies,
our study showed that low TG level is associated
with mortality in ICU patients with sepsis. This may be
due to alterations in serum lipid metabolism during sepsis,
modulating the host response to inflammation in critically
ill patients.
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